Syding, L. A., Nickl, P., Kasparek, P., & Sedlacek, R. (2020). CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review. Cells.
Citação norma ChicagoSyding, Linn Amanda, Petr Nickl, Petr Kasparek, and Radislav Sedlacek. "CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review." Cells 2020.
Citação norma MLASyding, Linn Amanda, Petr Nickl, Petr Kasparek, and Radislav Sedlacek. "CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review." Cells 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.